spacer
home > ebr > summer 2002 > beyond borders - ernst & young's global biotechnology report 2002
PUBLICATIONS
European Biopharmaceutical Review

Beyond Borders - Ernst & Young's Global Biotechnology Report 2002

Reflecting the reality in which the global biotechnology industry now operates, Ernst & Young's Global Health Sciences Group recently launched the latest of their well-known regional biotechnology industry reports as a single global document at the recent annual international BIO Convention in Toronto in June. Beyond Borders - The Global Biotechnology Industry Report 2002, or 'global book' as those who have become familiar with this excellent publication describe it, is an extremely useful report for all interested participants in today's biotechnology marketplace. It is to be applauded for capturing not only the most up-to-date benchmark data on growth and financing trends but also the essence of the most pertinent issues for the global biopharma sector today.Assembled from knowledge researched within the different regional territories of Ernst & Young's Global Health Sciences Team, the report is divided into two sections. The first, The Global Marketplace, sets out data and trends from the global industry principally represented by the 25 countries that have fostered the growth of the sector and which are also responsible for 79 per cent of global gross domestic product.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Helen Abbott, Senior Consultant at Technomark Consulting Services
spacer
Dr Helen Abbott
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

New offices at leading science hub support the Company’s rapid growth following recent investment New facility is in addition to headquarters at Babraham Research Campus, Cambridgeshire, UK and offices in Monmouth Junction, New Jersey, USA
More info >>

White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem — which CMO should you pick when each is touting similar technical capabilities?
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement